Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

about

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

Item

http://www.wikidata.org/entity/Q52724494

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

@en

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

@nl

type

Item

label

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

@en

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

@nl

prefLabel

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

@en

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

@nl

P1476

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers

@en

P2093

David Z Cherney

http://www.w3.org/2001/XMLSchema#string

Gozewijn D Laverman

http://www.w3.org/2001/XMLSchema#string

Ron T Gansevoort

http://www.w3.org/2001/XMLSchema#string

Sergei Petrykiv

http://www.w3.org/2001/XMLSchema#string

P2860

Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys

Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.

How does proteinuria cause progressive renal damage?

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics

Can we target tubular damage to prevent renal function decline in diabetes?

The role of inflammatory cytokines in diabetic nephropathy.

The proximal tubule and albuminuria: really!

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.

P304

1988-1993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DOM.13301

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claire C J Dekkers

Hiddo J L Heerspink

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29573529

http://www.w3.org/2001/XMLSchema#string

P932

6055757

http://www.w3.org/2001/XMLSchema#string